Harvest Management’s Terns Pharmaceuticals TERN Stock Holding History

Harvest Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-257,500	Closed	-$13.6M	–	87
2026 Q1	$13.6M	Buy	+257,500	New	+$10.6M	6.58%	4

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harvest Management's TERN Position: Q2 2026 in Review

Harvest Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 257,500 shares — an estimated $13.6M sold.

Harvest Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $13.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Harvest Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Harvest Management sold 257,500 Terns Pharmaceuticals shares in Q2 2026, an estimated $13.6M.
Harvest Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Harvest Management's Terns Pharmaceuticals position peaked at $13.6M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Harvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.